WHO and Pfizer Concerned About Access to New COVID Antiviral Paxlovid – But For Different Reasons 22/04/2022 Kerry Cullinan The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading -> Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Africa’s COVID-19 Vaccination Campaign Makes Slow Progress, Reaching Only 16.3% 21/04/2022 Kerry Cullinan Only 10 of Africa’s 54 countries have vaccinated more than a third of their citizens, although the continent has administered over two-thirds of the vaccine doses it has procured. The top 10 vaccinators are Seychelles (81%), Mauritius (76%), Rwanda (64%), Morocco (63%), Cape Verde (55%), Botswana (54%), Tunisia (53%), Mozambique (43%), São Tomé and Príncipe […] Continue reading -> Low COVID-19 Vaccine Coverage Undermines Eastern Mediterranean’s Plans To Welcome Pilgrims and Football Fans 20/04/2022 Aishwarya Tendolkar Some 42% of the World Health Organization’s (WHO) Eastern Mediterranean is fully vaccinated, but only five of the 22 member states have met the global goal of vaccinating 70% of their populations despite enough vaccine stocks being available, according to a media briefing on Wednesday. WHO Region Director for Eastern Mediterranean, Dr Ahmed Al-Mandhari, ascribed […] Continue reading -> Row Over COVID-19 Deaths Underscores the Importance of Accurate Mortality Statistics 20/04/2022 Kerry Cullinan The World Health Organization (WHO) expects to publish its COVID-19 death statistics “shortly”, despite objections from the government of India – apparently because the year-long study puts the Indian death toll at around four million while the government’s official death figure is 520,000 (to end 2021). The row between India and the WHO was first […] Continue reading -> US Will No Longer Enforce Masks for Travel While Mask-less European Airlines See Jump in Staff COVID Cases 19/04/2022 Raisa Santos The Biden administration will no longer enforce its mask mandate for travel after a federal judge in Florida struck down the US Centers for Disease Control and Prevention (CDC) mandate for planes, buses and trains Monday afternoon. US District Court Judge Kathryn Kimball Mizelle ruled in favor of the Health Freedom Defense Fund which had […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Could Mysterious Hepatitis Cases be Triggered by COVID-19? 21/04/2022 Maayan Hoffman More than 100 mysterious cases of hepatitis in children under the age of 10 around the world are raising a red flag among the medical community, with some doctors and scientists starting to hypothesise that the cases could be triggered by a new strain of adenovirus or even COVID-19. “Severe hepatitis in children is very […] Continue reading -> Africa’s COVID-19 Vaccination Campaign Makes Slow Progress, Reaching Only 16.3% 21/04/2022 Kerry Cullinan Only 10 of Africa’s 54 countries have vaccinated more than a third of their citizens, although the continent has administered over two-thirds of the vaccine doses it has procured. The top 10 vaccinators are Seychelles (81%), Mauritius (76%), Rwanda (64%), Morocco (63%), Cape Verde (55%), Botswana (54%), Tunisia (53%), Mozambique (43%), São Tomé and Príncipe […] Continue reading -> Low COVID-19 Vaccine Coverage Undermines Eastern Mediterranean’s Plans To Welcome Pilgrims and Football Fans 20/04/2022 Aishwarya Tendolkar Some 42% of the World Health Organization’s (WHO) Eastern Mediterranean is fully vaccinated, but only five of the 22 member states have met the global goal of vaccinating 70% of their populations despite enough vaccine stocks being available, according to a media briefing on Wednesday. WHO Region Director for Eastern Mediterranean, Dr Ahmed Al-Mandhari, ascribed […] Continue reading -> Row Over COVID-19 Deaths Underscores the Importance of Accurate Mortality Statistics 20/04/2022 Kerry Cullinan The World Health Organization (WHO) expects to publish its COVID-19 death statistics “shortly”, despite objections from the government of India – apparently because the year-long study puts the Indian death toll at around four million while the government’s official death figure is 520,000 (to end 2021). The row between India and the WHO was first […] Continue reading -> US Will No Longer Enforce Masks for Travel While Mask-less European Airlines See Jump in Staff COVID Cases 19/04/2022 Raisa Santos The Biden administration will no longer enforce its mask mandate for travel after a federal judge in Florida struck down the US Centers for Disease Control and Prevention (CDC) mandate for planes, buses and trains Monday afternoon. US District Court Judge Kathryn Kimball Mizelle ruled in favor of the Health Freedom Defense Fund which had […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa’s COVID-19 Vaccination Campaign Makes Slow Progress, Reaching Only 16.3% 21/04/2022 Kerry Cullinan Only 10 of Africa’s 54 countries have vaccinated more than a third of their citizens, although the continent has administered over two-thirds of the vaccine doses it has procured. The top 10 vaccinators are Seychelles (81%), Mauritius (76%), Rwanda (64%), Morocco (63%), Cape Verde (55%), Botswana (54%), Tunisia (53%), Mozambique (43%), São Tomé and Príncipe […] Continue reading -> Low COVID-19 Vaccine Coverage Undermines Eastern Mediterranean’s Plans To Welcome Pilgrims and Football Fans 20/04/2022 Aishwarya Tendolkar Some 42% of the World Health Organization’s (WHO) Eastern Mediterranean is fully vaccinated, but only five of the 22 member states have met the global goal of vaccinating 70% of their populations despite enough vaccine stocks being available, according to a media briefing on Wednesday. WHO Region Director for Eastern Mediterranean, Dr Ahmed Al-Mandhari, ascribed […] Continue reading -> Row Over COVID-19 Deaths Underscores the Importance of Accurate Mortality Statistics 20/04/2022 Kerry Cullinan The World Health Organization (WHO) expects to publish its COVID-19 death statistics “shortly”, despite objections from the government of India – apparently because the year-long study puts the Indian death toll at around four million while the government’s official death figure is 520,000 (to end 2021). The row between India and the WHO was first […] Continue reading -> US Will No Longer Enforce Masks for Travel While Mask-less European Airlines See Jump in Staff COVID Cases 19/04/2022 Raisa Santos The Biden administration will no longer enforce its mask mandate for travel after a federal judge in Florida struck down the US Centers for Disease Control and Prevention (CDC) mandate for planes, buses and trains Monday afternoon. US District Court Judge Kathryn Kimball Mizelle ruled in favor of the Health Freedom Defense Fund which had […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Low COVID-19 Vaccine Coverage Undermines Eastern Mediterranean’s Plans To Welcome Pilgrims and Football Fans 20/04/2022 Aishwarya Tendolkar Some 42% of the World Health Organization’s (WHO) Eastern Mediterranean is fully vaccinated, but only five of the 22 member states have met the global goal of vaccinating 70% of their populations despite enough vaccine stocks being available, according to a media briefing on Wednesday. WHO Region Director for Eastern Mediterranean, Dr Ahmed Al-Mandhari, ascribed […] Continue reading -> Row Over COVID-19 Deaths Underscores the Importance of Accurate Mortality Statistics 20/04/2022 Kerry Cullinan The World Health Organization (WHO) expects to publish its COVID-19 death statistics “shortly”, despite objections from the government of India – apparently because the year-long study puts the Indian death toll at around four million while the government’s official death figure is 520,000 (to end 2021). The row between India and the WHO was first […] Continue reading -> US Will No Longer Enforce Masks for Travel While Mask-less European Airlines See Jump in Staff COVID Cases 19/04/2022 Raisa Santos The Biden administration will no longer enforce its mask mandate for travel after a federal judge in Florida struck down the US Centers for Disease Control and Prevention (CDC) mandate for planes, buses and trains Monday afternoon. US District Court Judge Kathryn Kimball Mizelle ruled in favor of the Health Freedom Defense Fund which had […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Row Over COVID-19 Deaths Underscores the Importance of Accurate Mortality Statistics 20/04/2022 Kerry Cullinan The World Health Organization (WHO) expects to publish its COVID-19 death statistics “shortly”, despite objections from the government of India – apparently because the year-long study puts the Indian death toll at around four million while the government’s official death figure is 520,000 (to end 2021). The row between India and the WHO was first […] Continue reading -> US Will No Longer Enforce Masks for Travel While Mask-less European Airlines See Jump in Staff COVID Cases 19/04/2022 Raisa Santos The Biden administration will no longer enforce its mask mandate for travel after a federal judge in Florida struck down the US Centers for Disease Control and Prevention (CDC) mandate for planes, buses and trains Monday afternoon. US District Court Judge Kathryn Kimball Mizelle ruled in favor of the Health Freedom Defense Fund which had […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Will No Longer Enforce Masks for Travel While Mask-less European Airlines See Jump in Staff COVID Cases 19/04/2022 Raisa Santos The Biden administration will no longer enforce its mask mandate for travel after a federal judge in Florida struck down the US Centers for Disease Control and Prevention (CDC) mandate for planes, buses and trains Monday afternoon. US District Court Judge Kathryn Kimball Mizelle ruled in favor of the Health Freedom Defense Fund which had […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Shanghai Cases Surge as China Ramps Up “Zero-Tolerance” Policy to COVID-19 15/04/2022 Raisa Santos China’s financial hub Shanghai continues to see rising COVID-19 cases despite the country’s attempts at a “no COVID” policy. The city reported over 27,000 coronavirus cases on Thursday, a new high, following Chinese President Xi Jinping’s announcement a day earlier reinforcing the zero-tolerance approach to COVID. “Prevention and control work cannot be relaxed,” Xi said […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy